Multiple Myeloma: Prognosis and Standard Treatment

This publication has 37 references indexed in Scilit:

• Interferon plus Glucocorticoids as Intensified Maintenance Therapy Prolongs Tumor Control in Relapsed Myeloma
  Acta Haematologica, 1993
• Maintenance Treatment with Recombinant Interferon Alfa-2b in Patients with Multiple Myeloma Responding to Conventional Induction Chemotherapy
  New England Journal of Medicine, 1990
• Initial treatment in multiple myeloma: no advantage of multidrug chemotherapy over melphalan‐prednisone
  British Journal of Haematology, 1990
• VAD‐based regimens as primary treatment for multiple myeloma
  American Journal of Hematology, 1990
• Interferon in the Treatment of Refractory Multiple Myeloma: An Eastern Cooperative Oncology Group Study
  Leukemia & Lymphoma, 1990
• Ras oncogene mutation in multiple myeloma.
  The Journal of Experimental Medicine, 1989
• Induction and maintenance therapy in multiple myeloma: a multicenter trial of MP versus VCMP
  European Journal of Cancer and Clinical Oncology, 1988
• Evaluation of serum deoxythymidine kinase as a marker in multiple myeloma
  British Journal of Haematology, 1985
• The Chemotherapy of Plasma-Cell Myeloma and the Incidence of Acute Leukemia
  New England Journal of Medicine, 1979
• INTERFERON THERAPY IN MYELOMATOSIS
  The Lancet, 1979